The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and new product introductions. Sales reached Rs 19,711 crore, with cardiac, neuro/CNS, and anti-neoplastics segments significantly contributing to this expansion. Despite modest volume growth, effective pricing strategies and demand in chronic and acute care drove the industry’s success.Pharma sector continues to thrive, driven by price-led expansion
The Indian pharmaceutical market demonstrated robust growth in April 2025, achieving a 7.8% annual increase, fueled by price adjustments and new product introductions. Sales reached Rs 19,711 crore, with cardiac, neuro/CNS, and anti-neoplastics segments significantly contributing to this expansion. Despite modest volume growth, effective pricing strategies and demand in chronic and acute care drove the industry’s success.